Determinação de alguns produtos de degradação da azitromicina por cromatografia líquida de alta eficiência UV-vis em formas farmacêuticas comprimido revestido
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Azithromycin (AZM) is a broad-spectrum, semi-synthetic antibiotic from the macrolide family,
used for decades to treat infections caused by bacteria, such as pharyngitis and tonsillitis. During
the pandemic, its possible repositioning against the new coronavirus (SARS-Cov-2) was widely
publicized, however, the World Health Organization (WHO) does not recommend this therapy.
Drugs may contain impurities, which are inevitably produced during their synthesis route, but
may also originate throughout the shelf life of the drug, as degradation products. In the case of
AZM, these impurities can reduce the antibacterial activity and increase the toxicity of the drug.
Therefore, regulatory authorities describe that the impurity profile of a medicine is a critical
attribute of quality (CQA) and safety and thus, it has been triggering greater technical rigor and
global guidelines in this control. Impurities that exceed 0.1% must have their structures
confirmed to comply with the limits proposed by ICH (International Conference on
Harmonization of Requirements for Registration of Pharmaceutical Products for Human Use).
Therefore, it is important to identify AZM impurities, which are its structural analogues, and
monitor their presence and quantity in the medicine. This work proposed to evaluate the
analytical methods available in official compendia and make the necessary adjustments for the
analytical suitability by HPLC UV-vis detector in a multinational pharmaceutical industry (since
it had not been achieved previously), with consequent validation of the analytical method for
evaluating the known and unknown organic impurities arising from the degradation of AZM in
the medicine (finished product), demonstrating its selectivity, precision, accuracy, linearity and
robustness, in accordance with the specifications contained in RDC nr. 166/17. Finally, monitor
the quality of six batches from five different registration holders available on the Brazilian
market
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

